Hematopoietic chimerism as a predictive marker for the relapse of acute leukemia after
allogeneic BMT was evaluated in a prospective study. Monthly assays of hematopoietic …

Within a prospective study we analyzed hematopoietic chimerism in serial peripheral blood
samples taken from 55 patients with acute leukemias (ALL 21, AML 20, MDS 14) with a …

The role of chimerism analysis as a prognostic indicator of relapse after hematopoietic stem
cell transplantation (SCT) is controversial. We monitored chimerism status by short tandem …

BACKGROUND AND OBJECTIVES: The role of hematopoietic chimerism after allogeneic
stem cell transplantation (SCT) for acute leukemia remains controversial. We studied the …

Increasing mixed chimerism (MC) after allogeneic stem cell transplantation (SCT) has been
associated with a high risk of relapse in acute leukemia. We evaluated a new method for …

Hematopoietic chimerism (HpC) was assayed monthly using a sensitive, polymerase chain
reaction (PCR)-based method in consecutive patients. Between January 1998 and April …

OBJECTIVE: Chimerism is well-established for surveillance of acute myeloid leukemia
(AML) patients after allogeneic hematopoietic stem cell transplantation (HSCT), but …

This study evaluates the prognostic significance of quantitative chimerism to monitor minimal
residual disease and predict relapse in acute leukemia (AL) patients following allogeneic …

Recent observations of chimerism in patients relapsed following an allotransplant suggest
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …

Highly polymorphic tandemly repetitive DNA sequences provide powerful genetic markers
for the identification of individuals by restriction fragment length polymorphisms (RFLP) even …